Home > Cancer Types


University of Michigan study challenges notion of using Herceptin only for HER2-positive breast cancer

Tuesday, February 26, 2013 - 15:15
New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread.

U-M Breast Oncology Program benefits from televised charitable shoe sale on QVC

Wednesday, June 5, 2013 - 15:30

QVC and FFANY present U-M Cancer Center with nearly $400,000

Written by Nicole Fawcett

ANN ARBOR, Mich. - With thousands of shoes offered at half the manufacturer's suggested retail price* during the 19th annual QVC Presents "FFANY Shoes on Sale," it was easier than ever for shoe lovers to take another step forward in the fight against breast cancer.


Subscribe to Breast